Exact Sciences (EXAS) 7th Annual Healthcare Symposium summary

Key industry challenges and trends

• Aging populations are driving increased healthcare spending, projected to reach 20% of U.S. GDP by the early 2030s.

• Cancer incidence and mortality are expected to rise significantly by 2050, highlighting the need for improved early detection and access to care.

• Vaccine access remains unequal globally, with higher-income populations consuming the majority of vaccines.

• Longevity pressures, technology advancements, and incentive alignment are central challenges for the healthcare sector.

Symposium agenda and objectives

• Panels addressed multi-cancer early detection (MCED), consumer empowerment, aging in place, and vaccine access.

• The event aimed to foster discussion, learning, and collaboration among students, alumni, and industry leaders.

• Q&A sessions encouraged active audience participation to advance healthcare dialogue.

Approaches to multi-cancer early detection

• Quest focuses on access, partnerships, and whole-health approaches, including a new risk test with MD Anderson.

• Exact Sciences leverages its Cologuard brand and infrastructure to expand from colorectal to multi-cancer detection.

• Guardant Health uses a unified tech stack for blood-based detection, starting with colorectal and expanding to other cancers.

• Grail’s Galleri test detects up to 50 cancers via a shared blood signal, requiring significant education for adoption.